Myriad Asset Management Ltd. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Myriad Asset Management Ltd. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2015$5,586,000
+264.9%
3,500,000
+250.0%
0.64%
+329.1%
Q1 2015$1,531,0001,000,0000.15%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2015
NameSharesValueWeighting ↓
SCHRODER INVESTMENT MANAGEMENT GROUP 12,400,000$1,326,025,000,0001.66%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$8,643,0000.79%
OAKTREE CAPITAL MANAGEMENT LP 37,500,000$40,523,0000.74%
ADVENT CAPITAL MANAGEMENT /DE/ 46,800,000$50,350,0000.63%
Jabre Capital Partners S.A. 6,500,000$7,035,0000.54%
Nicholas Investment Partners, LP 6,470,000$6,919,0000.53%
Polar Asset Management Partners Inc. 10,000,000$10,788,0000.46%
AVIVA PLC 50,700,000$54,594,0000.46%
Man Investments (CH) AG 1,000,000$1,082,0000.44%
RWC Asset Management LLP 3,500,000$3,769,0000.40%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders